ArticleJournal of paediatrics and child health2026
Partnered Pharmacist Medication Charting for Children and Young People: A Retrospective Cohort Study.
Article in Journal of paediatrics and child health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimPartnered pharmacist medication charting (PPMC) reduces medication errors in Australian adult hospitals. This study evaluated the impact of PPMC on paediatric emergency department (ED) presentations compared to early best possible medication history (BPMH) and usual care.
methodsA retrospective cohort study was conducted at a tertiary paediatric hospital with electronic medication management systems, comparing three sequential models of care across three time periods: usual care (T1), early BPMH by an ED pharmacist (T2), and PPMC (T3). The primary outcome was the proportion of patients with one or more medication errors, assessed for clinical significance by a blinded expert panel. Secondary outcomes included length of stay (LOS) and medication-related documentation completion.
resultsThe percentage of patients with one or more medication errors identified was 70.6% in usual care (T1, n = 126), 50.8% in early BPMH (T2, n = 122), and 5.8% in PPMC (T3, n = 103). The absolute risk reduction for T3 PPMC compared to T1 Usual care (ARR T1 vs. T3) was 0.65 (95% CI 0.558-0.742) with one medication error prevented for every two patients receiving PPMC (NNT = 2, 95% CI 2-2). The median LOS was 3.3 days in usual care (T1) and 2.3 days in PPMC (T3) (p = 0.012).
conclusionsPPMC substantially reduced medication errors and the prevalence of high or extreme risk errors. The benefit extended beyond error prevention, with improvements in medication reconciliation, dosing weight documentation, and allergy review, and an association with shorter LOS. These findings support PPMC as a scalable approach to medication safety in paediatric hospitals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.